The U.S. Food and Drug Administration today announced its initial review of the effectiveness of the FDA ImportShield Program (FISP), which launched in August 2025 to modernize how the FDA reviews imported products.
FDA ImportShield Program Delivers Impressive Results in Strengthening FDA Oversight at U.S. Ports of Entry
FDA announced the initial review of the ImportShield Program (FISP), launched in August 2025 to modernize how the FDA reviews imported products. In four months, FISP increased processing speed by 66%, boosted monthly volume capacity by 33%, and reduced staff hours by 20% (about 3,388 hours per month). The program consolidates five regional teams into…
border control Border protection BorderControl CBP integration consumer protection consumer safety counterfeit drugs counterfeit medications drug safety FDA FISP Food and Drug Safety Food safety FoodAndDrugAdministration import regulation import review import reviews import safety import surveillance Imports ImportShield Infant formula modernization Pharmaceutical Safety pharmaceuticals Port of entry ports of entry public health PublicHealth regulatory modernization Regulatory Oversight regulatory program regulatory technology RegulatoryTechnology supply chain Supply chain security tainted infant formula technology modernization U.S. Ports of Entry